Our Bureau

Mumbai, Nov. 24

Zydus Cadila has filed an Investigational New Drug (IND) application with the Drug Controller General of India for the new molecular entity ZY01, a drug candidate for treating obesity and related disorders.

ZYO1 is an experimental drug to help obese patients lose weight and control blood sugar levels in type-2 diabetes.

"ZYO1 has shown remarkable efficacy and a clean toxicity profile in pre-clinical trials. It holds promising commercial potential in the absence of effective treatments for obesity and related disorders," said Mr Pankaj Patel, Chairman and Managing Director of Zydus Cadila. Zydus Cadila plans to initiate clinical trials to ensure the safety and tolerability of ZYO1.

(This article was published in the Business Line print edition dated November 25, 2006)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.